Striatum Hyperactivity Triggers Relapse to Morphine and Methamphetamine (Polydrug) Dependence in Mice.

INTRODUCTION

κ-opioid receptor (KOPr) system has been linked to relapse to many substances, especially opioids. Positive responses were recently reported in morphine and methamphetamine (polydrug)-dependent mice treated with buprenorphine and naltrexone, a functional κ antagonist.

OBJECTIVES

This study aimed to determine the specific brain region that is responsive to KOPr treatment following polydrug dependence.

MATERIALS AND METHODS

The polydrug-dependent mice model was developed using conditioned place preference (CPP) method. Following successful withdrawal phase, the mice were treated with 0.3 mg/kg buprenorphine and 1.0 mg/kg naltrexone. Four brain regions (hippocampus, prefrontal cortex, amygdala, and striatum) were investigated using immunohistochemistry technique. This is to quantify the changes in KOPr expression in each major brain region that was primarily involved in addiction neurocircuits of many substances. Unpaired Student's test was used to analyze all results, where < 0.05 is considered significant.

RESULTS

The results showed that treatment with buprenorphine and naltrexone successfully attenuated relapse in 60% of mice ( = 14). A significant upregulation of KOPr was detected in striatum at the end of post-withdrawal phase ( < 0.01, = 12). This treatment successfully suppressed KOPr in striatum ( < 0.001, = 12), which supports the positive results seen in the CPP setting. No significant changes were observed in other brain regions studied.

CONCLUSION

The hyperactivity of striatum suggests that the affected brain region following KOPr antagonist treatment is the region that primarily controls the drug rewarding activity, in which nucleus accumbens is located. This indicates that manipulation of KOPr system is one of the potential targets to treat morphine- or methamphetamine-dependence problem.